Trent has seen a 36.5% drop in its share price in the last 12 months and offers an attractive combination of low valuation, earnings resilience in recent quarters, and a relatively high RoNW of 29%
Analysts remain positive on the stock, citing expansion plans across thermal, wind and solar power
The Thermax stock has dropped 37.9 per cent in the trailing 12 months to September, underperforming the BSE Sensex, which is down just 4.8 per cent
The Adani group-owned cement major has seen a sustained slide in both share price and equity valuation over the past 12 months
Colgate's prospects remain supported by its core toothpaste brands and premiumisation strategy through science-backed innovations, with valuations appearing fair at 42x FY27 earnings
TCS and the broader IT sector stand to gain from stable pricing, opportunities in agentic AI, and momentum in BFSI and hi-tech segments
Over a quarter of BSE200 stocks are down 20 per cent, leading to a sharp fall in their equity valuation, creating opportunities for investors
The Q1 was impacted by sluggish show of the base business and supply disruption, resulting in brokerages cutting their earnings estimates
PI Industries stock has fallen 18 per cent since August on weak Q1 results, muted export outlook and biologics curbs, though brokerages remain positive on long-term growth
Pricing challenges, muted domestic growth offset gains in exim volumes
The key trigger for the sector and listed companies are trends in housing sales. Data on this front does not look favourable
TVS Motor's stock is expected to gain further with GST rate cuts, premiumisation, new scooter launches, and robust sales momentum in domestic and export markets
Multiple triggers could help Apollo Hospitals to reverse underperformance
Among listed companies, Kansai Nerolac has the highest exposure to the auto segment, with 30 per cent of its sales coming from this segment
But expansion in Andhra, policy support in UP can catalyse full-bodied growth
Sport utility vehicle launches and market resets inject horsepower into the automotive sector, turning the carmaker into a pacesetter of the rally
Zydus Lifesciences trades near 52-week highs on strong growth and acquisitions but analysts caution that rapid expansion and diversification may pose execution challenges
Order wins, strong pipeline, and long-term defence projects drive optimism in Bharat Electronics, with revenue growth visibility and major contracts like QRSAM and Project Kusha ahead
Tax tweaks and fresh launches give footwear major a leg up on rivals
Ashok Leyland stock gained after Q1 results on stronger margins and GST cut hopes, but muted commercial vehicle demand and cyclicality may limit upside